How Much Did Phoenix Bioinformatics Raise?
Funding & Key Investors

Phoenix Bioinformatics has successfully secured a major strategic investment, marking a significant milestone in its operational trajectory. With a cumulative capital influx reaching $150K, the organization continues to solidify its position as a critical infrastructure provider for the global scientific community. This latest financing round, totaling $150K, underscores the increasing market demand for robust, sustainable research data management solutions in an era of accelerating academic and commercial discovery.

What is Phoenix Bioinformatics?

Phoenix Bioinformatics
Business ServicesResearch & DevelopmentDocument Management

Phoenix Bioinformatics operates at the intersection of data science and academic research, providing essential services that ensure the longevity and accessibility of complex datasets. The firm specializes in comprehensive data warehousing, sustainability design, and meticulous curation, serving a diverse clientele that includes university libraries, government agencies, and nonprofit research institutions. By managing high-impact databases such as TAIR and MorphoBank, the company addresses the critical challenge of data decay, offering professional subscription management and infrastructure support that allows researchers to focus on primary discovery rather than technical maintenance. Their market position is defined by a commitment to making research data both usable and affordable on a global scale.

How much funding has Phoenix Bioinformatics raised?

Phoenix Bioinformatics has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Phoenix Bioinformatics

PPP

Public-Private Partnership

What's next for Phoenix Bioinformatics?

Following this late-stage capital injection, Phoenix Bioinformatics is well-positioned to scale its service offerings and enhance its technological stack. The strategic focus will likely shift toward expanding its footprint within the commercial research sector while deepening its integration with existing university library systems. As the volume of global research data continues to grow exponentially, the company is poised to leverage this investment to refine its curation methodologies and potentially introduce new automated data management tools. By maintaining its focus on long-term data sustainability, Phoenix Bioinformatics is set to remain a cornerstone of the modern research ecosystem, bridging the gap between raw data generation and actionable scientific insight.

See full Phoenix Bioinformatics company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesField Service Management
Business ServicesResearch & Development
Business ServicesCommercial Printing
Advertising NetworksBusiness ServicesRetailVitamins, Supplements & Health Stores

Frequently Asked Questions Regarding Phoenix Bioinformatics Financial Insights

What are the most recent funding rounds that Phoenix Bioinformatics has completed, and what were the funding rounds?
Phoenix Bioinformatics has recently completed 1 funding rounds: Debt on Apr 14, 2020.
What is the total amount of funding Phoenix Bioinformatics has raised to date?
Phoenix Bioinformatics has raised a total of $150K in funding to date.
How many funding rounds has Phoenix Bioinformatics completed?
Phoenix Bioinformatics has completed 1 funding rounds.
How much funding did Phoenix Bioinformatics raise in its most recent funding round?
Phoenix Bioinformatics raised $150K in its most recent funding round.
Who are the lead investors in Phoenix Bioinformatics's latest funding round?
The lead investor in Phoenix Bioinformatics's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Phoenix Bioinformatics's history?
The largest funding round in Phoenix Bioinformatics's history was $150K.
See more information about Phoenix Bioinformatics